DYRK kinases phosphorylate IL-17RA at S801

Authors

  • Sayed Ala Moududee Author
  • Andrew A. Herppich Author
  • Mary Kay H. Pflum Author
  • Dongxia Ge Author
  • Zongbing You Tulane University Author

DOI:

https://doi.org/10.17161/sjm.v3i3.25722

Keywords:

IL-17RA, DYRK, In vitro kinase assay, Serum starvation, Inhibitor

Abstract

Interleukin-17 (IL-17) receptor A (IL-17RA) promotes inflammatory reactions by activating kinases and transcription regulators. Our previous studies have demonstrated that glycogen synthase kinase 3 (GSK3) phosphorylates IL-17RA at T780. It is not known whether other kinases also phosphorylate IL-17RA. Here, we identified an association between dual‑specificity tyrosine-regulated kinases (DYRKs) and IL-17RA. We found that DYRK1B and DYRK4 interacted with and phosphorylated IL-17RA at serine 801 (S801). Overexpression of DYRK1B and DYRK4 enhanced IL-17RA phosphorylation, whereas siRNA-mediated knockdown of DYRK1B or DYRK4 reduced the phosphorylation. Serum starvation of the cultured cells increased expression levels of DYRK1B/4 and IL-17RA phosphorylation, suggesting stress-dependent modulation of receptor modification. Moreover, selective small‑molecule inhibitors of DYRKs effectively suppressed IL-17RA phosphorylation at S801. Our findings indicate a link between DYRK family kinases and IL-17RA phosphorylation, providing new potential therapeutic targets in the management of IL-17-mediated diseases.

Downloads

Published

08/28/2026

Data Availability Statement

All data are contained in the text.

Issue

Section

Original Research

How to Cite

1.
Moududee SA, Herppich AA, Pflum MKH, Ge D, You Z. DYRK kinases phosphorylate IL-17RA at S801. Serican J. Med. 2026;3(3). doi:10.17161/sjm.v3i3.25722

Most read articles by the same author(s)

<< < 1 2